Rigel Pharmaceuticals, Inc. (RIGL)
43.08
-0.93
(-2.11%)
USD |
NASDAQ |
Dec 29, 16:00
43.04
-0.04
(-0.09%)
After-Hours: 20:00
Rigel Pharmaceuticals Shareholders Equity (Quarterly): 117.61M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Catalyst Pharmaceuticals, Inc. | 920.24M |
| Perspective Therapeutics, Inc. | 242.22M |
| Nektar Therapeutics | 85.09M |
| Vertex Pharmaceuticals, Inc. | 17.32B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 242.53M |
| Total Liabilities (Quarterly) | 124.92M |
| Debt to Equity Ratio | 0.5176 |
| Current Ratio | 2.277 |
| Net Debt Paydown Yield | -0.02% |